Please login to the form below

Not currently logged in
Email:
Password:

Stiefel

This page shows the latest Stiefel news and features for those working in and with pharma, biotech and healthcare.

Langland and CAHG take top prizes at Best of Health Awards

Langland and CAHG take top prizes at Best of Health Awards

Healthcare Professional - Digital Media. 'Behind the Façade' for Stiefel, by DJM Unlimited Richmond .

Latest news

  • GSK unit takes new ofatumumab formulation into phase III GSK unit takes new ofatumumab formulation into phase III

    GlaxoSmithKline's dermatology unit Stiefel has started a phase III trial of ofatumumab in a rare and life-threatening autoimmune disorder of the skin.

  • Alkermes cuts jobs in Ireland as Novartis invests Alkermes cuts jobs in Ireland as Novartis invests

    GSK also elected not to close a plant in Sligo operated by its Stiefel subsidiary.

  • GSK reverses closure of Irish manufacturing facility GSK reverses closure of Irish manufacturing facility

    GSK reverses closure of Irish manufacturing facility. But will initially cut staff numbers at Stiefel's Sligo plant by a third. ... Looking to the future, Sligo will play an important role in our Stiefel consumer business.”.

  • Pharma deals for June 2012 Pharma deals for June 2012

    Under the agreement, Stiefel will assume responsibility for the further development, manufacturing, commercialisation, and worldwide distribution. ... Basilea/ Stiefel Labs (GSK). Acquisition. Toctino (alitretinoin), oral retinoid for severe chronic hand

  • GSK signs eczema drug deal with Basilea GSK signs eczema drug deal with Basilea

    As part of the deal, Stiefel will acquire all rights to Toctino and will license certain clinical information from Basilea. ... Stiefel would in turn be responsible for the product's further development, manufacture and commercialisation worldwide.

More from news
Approximately 1 fully matching, plus 26 partially matching documents found.

Latest appointments

  • David Kendall joins Alimentary Health David Kendall joins Alimentary Health

    Kendall brings to the role over 25 years of commercial experience, having held positions at Chefaro Pharmaceuticals, GlaxoSmithKline, Quest Vitamins and Stiefel Laboratories.

  • Michael Le Brocq joins Langland Michael Le Brocq joins Langland

    Joining from ICC Lowe London, where he was head of strategy, Le Brocq has held senior pharmaceutical marketing roles at Parke-Davis (Pfizer), Novartis and Stiefel.

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Adelphi Research UK

Adelphi Research UK is a healthcare insight partner. We uniquely blend robust market research with a consultancy approach, to guide...

Latest intelligence

Solaris Health looks at the gene therapy revolution
Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...
PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...

Infographics